trending Market Intelligence /marketintelligence/en/news-insights/trending/NcvAeDPYOh9WSfmqt2_p6Q2 content esgSubNav
In This List

Walgreens forms German pharmaceutical JV with McKesson

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Earnings forecasts for US banks; corporate deleveraging; LatAm currency gains


Walgreens forms German pharmaceutical JV with McKesson

Walgreens Boots Alliance Inc. and McKesson Corp. agreed to form a joint venture combining their pharmaceutical wholesale businesses in Germany, according to a joint release Dec. 12.

Walgreens will own 70% of the joint venture and McKesson will hold the remaining 30% interest.

The business will combine the operations of Walgreens' Alliance Healthcare Deutschland AG and McKesson's GEHE Pharma Handel in Germany.

The companies said they expect the new venture to drive greater economies of scale for both parties and boost the competitiveness of the German pharmaceutical wholesale market.

Financial terms of the transaction were not disclosed.

Walgreens and McKesson will have proportional representation on the joint venture's supervisory board. The deal is expected to be completed in at least six months, subject to merger clearance and approval by customary authorities.